Kazia Therapeutics (KZIA) Non-Current Deferred Tax Liability (2017 - 2025)

Kazia Therapeutics (KZIA) has disclosed Non-Current Deferred Tax Liability for 6 consecutive years, with $174197.8 as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Non-Current Deferred Tax Liability fell 86.9% year-over-year to $174197.8, compared with a TTM value of $174197.8 through Jun 2025, down 86.9%, and an annual FY2025 reading of $176291.2, down 86.68% over the prior year.
  • Non-Current Deferred Tax Liability was $174197.8 for Q2 2025 at Kazia Therapeutics, down from $1.3 million in the prior quarter.
  • Across five years, Non-Current Deferred Tax Liability topped out at $1.8 million in Q2 2022 and bottomed at $174197.8 in Q2 2025.
  • Average Non-Current Deferred Tax Liability over 4 years is $1.2 million, with a median of $1.4 million recorded in 2023.
  • The sharpest move saw Non-Current Deferred Tax Liability dropped 13.07% in 2024, then tumbled 86.9% in 2025.
  • Year by year, Non-Current Deferred Tax Liability stood at $1.8 million in 2022, then dropped by 16.57% to $1.5 million in 2023, then dropped by 13.07% to $1.3 million in 2024, then crashed by 86.9% to $174197.8 in 2025.
  • Business Quant data shows Non-Current Deferred Tax Liability for KZIA at $174197.8 in Q2 2025, $1.3 million in Q2 2024, and $1.5 million in Q2 2023.